95 papers
Cardiovascular medicine focuses on the heart and blood vessels, exploring how to prevent, diagnose, and treat conditions that affect our circulation. This vital field ranges from understanding high blood pressure and heart failure to investigating the latest breakthroughs in surgical techniques and lifestyle interventions. Because these discoveries directly impact public health, staying informed about emerging research is more important than ever for both specialists and curious readers.
At Gist.Science, we process every new preprint in this category as it appears on medRxiv, ensuring you have immediate access to the latest findings before they undergo formal peer review. For each study, we provide both a plain-language explanation to clarify the core concepts and a detailed technical summary for those seeking deeper scientific context. Below are the latest papers in cardiovascular medicine, organized to help you navigate the most recent developments shaping the future of heart health.
The paper introduces CASCADE, a personalized, online anomaly forecasting framework that utilizes entropy-tuned chaotic reservoir computing to detect early cardiac arrhythmias by identifying failures in short-term dynamical predictability rather than relying on static beat-level classification.
Using causal machine learning on real-world electronic health records, this study found that GLP-1 receptor agonists are associated with a lower risk of all-cause mortality or heart failure hospitalization compared to SGLT2 inhibitors in heart failure patients, though evidence for individualized treatment selection remains limited.
In the tri-ethnic SABRE study, poor sleep quality was significantly associated with increased left ventricular mass in South Asian and African/African-Caribbean participants, but not in Europeans, suggesting ethnic-specific links between sleep and cardiovascular structural changes.
This exploratory Granger causality study demonstrates that beat-to-beat functional mitral regurgitation is driven by heterogeneous, subtype-specific temporal dynamics, where ventricular loading dominates short-term prediction in ventricular cases while atrial volume and papillary muscle interactions govern longer-term patterns in atrial cases.
CorSeg-CineSAX is an open-source deep learning framework that utilizes a large-scale, multi-center dataset and an anatomically constrained post-processing pipeline to achieve robust, fully automatic segmentation of cardiac MRI across diverse and previously unseen disease categories with high clinical agreement.
In a randomized trial, instantaneous wave-free ratio (iFR)-guided coronary artery bypass grafting significantly improved 36-month graft patency for both left internal mammary artery and saphenous vein grafts compared to conventional angiography-guided CABG by optimizing target selection and reducing competitive flow, although major adverse cardiac and cerebrovascular events remained similar between the two groups.
The BECAME-HF project utilized plasma lipidomics to identify distinct, clinically relevant HFpEF phenogroups across Belgian and Canadian cohorts, revealing a specific high-risk metabolic signature characterized by severe organ dysfunction and reduced survival.
This retrospective study demonstrates that the Kurume-HEARTS program, which utilizes planned hospitalizations for structured education and management, significantly reduces total hospitalization costs and length of stay per person-year compared to unplanned admissions for patients with recurrent heart failure.
This paper introduces and validates an easily implemented ordinal logistic regression method for covariate adjustment in win ratio analyses of hierarchical outcomes, demonstrating that adjusting for prognostic variables consistently improves statistical power without compromising efficiency.
This systematic review and meta-analysis indicates that low-dose colchicine reduces major adverse cardiovascular events in patients with established atherosclerotic cardiovascular disease, though substantial heterogeneity driven by timing of initiation and cumulative dose suggests that clinical benefits vary significantly across settings, with acute-phase treatment showing no benefit compared to sub-acute or chronic administration.